Metoprolol Tartrate Injection, Solution
Product Images NDC 25021-303

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metoprolol Tartrate (NDC 25021-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Met04 0012 01

Met04 0012 01
Chemical structure diagram of Metoprolol Tartrate, showing the molecular arrangement of the active ingredient Metoprolol Tartrate as indicated in the product data for the intravenous injection solution.*
FDA Label Image

Met04 0012 02

Met04 0012 02
Label for Metoprolol Tartrate Injection, USP, 1 mg/mL strength in a 5 mL single-dose vial for intravenous use. The label shows the proprietary name, strength prominently displayed as 5 mg per 5 mL, storage and usage instructions, manufacturer information for Sagent Pharmaceuticals, and space for lot and expiration dates. Barcode present on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.